![Cui Ping Gu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cui Ping Gu
Direttore/Membro del Consiglio presso
Cullgen, Inc.
Profilo
Cui Ping Gu is currently working as a Director at Cullgen, Inc. Prior to this, Dr. Gu served as a Non-Executive Director at QuantumPharm, Inc. from 2018 to 2024.
Dr. Gu also worked as a Project Manager at Eli Lilly & Co. Dr. Gu holds a doctorate degree from Shanghai Jiao Tong University, which was conferred in 2007.
Additionally, Dr. Gu obtained an undergraduate degree from Shanghai Jiao Tong University in 2002.
Posizioni attive di Cui Ping Gu
| Società | Posizione | Inizio |
|---|---|---|
Cullgen, Inc.
 Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focused on discovery and development of targeted protein degrader and DAC therapies for cancer and inflammatory & pain diseases | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Cui Ping Gu
| Società | Posizione | Fine |
|---|---|---|
| XTALPI HOLDINGS LIMITED | Direttore/Membro del Consiglio | 30/10/2024 |
Formazione di Cui Ping Gu
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
92
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Shanghai Jiao Tong University
 Shanghai Jiao Tong University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cullgen, Inc.
Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focused on discovery and development of targeted protein degrader and DAC therapies for cancer and inflammatory & pain diseases | Health Technology |
QuantumPharm, Inc.
 QuantumPharm, Inc. BiotechnologyHealth Technology Operates as an investment holding company that engages in provision of drug discovery and intelligent automation solutions | Health Technology |
